Pathology/Lab Coding Alert

Reader Question:

Don't Forget New CTC Code

Question: Our lab performs the CellSearch® test to evaluate circulating tumor cells in patient blood specimens following treatment for breast, colon, or colorectal cancer. We've been coding the test as 88361 x 2 -- is that correct?Colorado SubscriberAnswer: No, 88361 (Morphometric analysis, tumor immunohistochemistry [e.g., Her-2/neu, estrogen receptor/progesterone receptor], quantitative or semiquantitative, each antibody; using computer-assisted technology) is not the correct coding for a circulating tumor cell (CTC) blood test after Jan. 1, 2012.Here's why: CPT 2012 adds the following two new Category III codes for a CTC in blood specimens:0279T -- Cell enumeration using immunologic selection and identification in fluid specimen [e.g., circulating tumor cells in blood)0280T -- ... interpretation and report.Technical or professional: Note that one code represents the technical component of the test (0279T), and the other code represents the professional component (0280T). Make sure you bill only the part of the test your lab or pathologist performs. That rule [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Pathology/Lab Coding Alert

View All